<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with long-standing <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD) have an increased risk of developing <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Many of the molecular alterations responsible for <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, namely <z:mp ids='MP_0008866'>chromosomal instability</z:mp>, microsatellite instability, and hypermethylation, also play a role in <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated colon <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0003003'>Colon cancer</z:hpo> risk in <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> increases with longer duration of <z:hpo ids='HP_0002583'>colitis</z:hpo>, greater anatomic extent of <z:hpo ids='HP_0002583'>colitis</z:hpo>, the presence of primary sclerosing <z:mp ids='MP_0003254'>cholangitis</z:mp>, family history of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and degree of <z:mp ids='MP_0001845'>inflammation</z:mp> of the bowel </plain></SENT>
<SENT sid="3" pm="."><plain>Chemoprevention includes aminosalicylates, <z:chebi fb="1" ids="9907">ursodeoxycholic acid</z:chebi>, and possibly <z:chebi fb="9" ids="27470">folic acid</z:chebi> and <z:chebi fb="0" ids="35664">statins</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>To reduce <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> mortality in IBD, colonoscopic surveillance with random biopsies remains the major way to detect early mucosal <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>When <z:mpath ids='MPATH_589'>dysplasia</z:mpath> is confirmed, proctocolectomy is considered for these patients </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with small intestinal <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> are at increased risk of small bowel <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0100279'>Ulcerative colitis</z:hpo> patients with total proctocolectomy and ileal pouch anal-anastomosis have a rather low risk of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in the ileal pouch, but the anal transition zone should be monitored periodically </plain></SENT>
<SENT sid="8" pm="."><plain>Other extra <z:e sem="disease" ids="C0346627" disease_type="Neoplastic Process" abbrv="">intestinal cancers</z:e>, such as hepatobiliary and <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematopoietic cancer</z:e>, have shown variable incidence rates </plain></SENT>
<SENT sid="9" pm="."><plain>New endoscopic and molecular screening approaches may further refine our current surveillance guidelines and our understanding of the natural history of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
</text></document>